← Back to Search

Exercise for Sleep and Inflammation in HIV (REST Trial)

N/A
Recruiting
Research Sponsored by Christine Horvat Davey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Confirmed HIV infection
On a current, modern antiretroviral therapy (ART) (anti-retroviral regimen)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-8 weeks and 0-16 weeks
Awards & highlights

REST Trial Summary

This trial will compare the effects of two types of exercise on sleep and inflammation in older people with HIV.

Who is the study for?
This trial is for people over 50 living with HIV who have poor sleep quality, are on modern antiretroviral therapy, and lead a sedentary lifestyle. They must not have uncontrolled high blood pressure, serious heart conditions without clearance, or severe pulmonary disease requiring oxygen.Check my eligibility
What is being tested?
The study tests how two types of exercise—high-intensity interval training (HIIT) and continuous moderate-intensity exercise (CME)—affect sleep and inflammation in older adults with HIV. Participants will be randomly assigned to one of the exercise programs for 16 weeks.See study design
What are the potential side effects?
While specific side effects aren't listed for HIIT or CME, general risks may include muscle soreness, fatigue, increased heart rate during exercise, and potential exacerbation of existing health issues.

REST Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am HIV positive.
Select...
I am on a modern HIV treatment regimen.
Select...
I have poor sleep quality according to the Pittsburgh Sleep Quality Index.
Select...
I am 50 years old or older.

REST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-8 weeks and 0-16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-8 weeks and 0-16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Interleukin inflammation markers
Mean sleep duration
Sleep efficiency
+2 more
Secondary outcome measures
C-reactive protein inflammation marker
Interferon gamma inflammation marker
Inflammation

REST Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High intensity interval trainingExperimental Treatment1 Intervention
Group II: Continuous moderate intensity exerciseActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HIIT
2011
N/A
~730

Find a Location

Who is running the clinical trial?

University of WashingtonOTHER
1,740 Previous Clinical Trials
1,847,888 Total Patients Enrolled
University of Colorado, DenverOTHER
1,734 Previous Clinical Trials
2,148,833 Total Patients Enrolled
Christine Horvat DaveyLead Sponsor

Media Library

CME Clinical Trial Eligibility Overview. Trial Name: NCT04946994 — N/A
HIV (Human Immunodeficiency Virus) Research Study Groups: High intensity interval training, Continuous moderate intensity exercise
HIV (Human Immunodeficiency Virus) Clinical Trial 2023: CME Highlights & Side Effects. Trial Name: NCT04946994 — N/A
CME 2023 Treatment Timeline for Medical Study. Trial Name: NCT04946994 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently open to participants in this research?

"As evidenced by the details on clinicaltrials.gov, this experiment is seeking volunteers; it was first posted in October of 2021 and recently revisited during February 2022."

Answered by AI

How many patients are being recruited into this research program?

"Affirmative. According to data on clinicaltrials.gov, this medical investigation is actively attempting to find participants, having been initially posted in October of 2021 and edited as recently as February 10th 2022. The study requires 50 individuals at 2 sites for completion."

Answered by AI
~7 spots leftby Oct 2024